Physician profile
Elias E Khalfayan
NPI 1851360382
$25,672.08
in general payments reported to CMS, 2019-2025
6 companies · $4,241 in 2025
The $4,241 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,575 · 2021: $3,869 · 2022: $4,385 · 2023: $3,496 · 2024: $2,105 · 2025: $4,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,293 · Food and Beverage: $2,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,293.30 |
| Food and Beverage | $2,549.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,446.52 | 2021-2025 | |
| Vericel Corporation | $7,575.05 | 2019 | |
| Rti Surgical, INC | $3,450.00 | 2021 | |
| Summit Surgical Corp. | $3,426.35 | 2022-2023 | |
| Miach Orthopaedics, INC. | $1,600.14 | 2025 | |
| Invictus Surgical Incorporated | $1,174.02 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elias Khalfayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.